Epilepsy Syndromes in Children - Childhood Onset Flashcards
epilepsy syndromes of childhood
range from relatively common and more benign disorders (including focal-onset seizure type as in benign rolandic epilepsy and the early- and late-onset forms of benign occipital epilepsy and generalized-onset forms such as childhood absence epilepsy) to epileptic encephalopathies raging from Lennox-Gastaut syndrome to epileptic encephalopathy with continuous spike and wave in slow sleep (CSWS)
genetic epilepsy with febrile seizures plus
familial electroclinical syndrome that can have onset in infancy or childhood
genetic epilepsy with febrile seizures plus - genetics
associated in at least some cases with mutations of the SCN1A gene encoding for a voltage-gated sodium channel subunit
genetic epilepsy with febrile seizures plus - seizure types
both generalized and focal seizures may occur
genetic epilepsy with febrile seizures plus - diagnosis
at least 2 family members should be affected to establish the diagnosis clinically
genetic epilepsy with febrile seizures plus - phenotypes
range from simple febrile seizures to mixed febrile and afebrile seizures that may be prolonged, focal, or occur in clusteres
genetic epilepsy with febrile seizures plus - clinical distinction between Dravet and Doose syndromes
may be challenging
hippocampal sclerosis may occur (sign of prolonged febrile seizure)
genetic epilepsy with febrile seizures plus - onset
usually between 6mo and 6 years of age
boys and girls affected equally
genetic epilepsy with febrile seizures plus - development
develop normally
genetic epilepsy with febrile seizures plus - inheritance
autosomal dominant with incomplete penetrance
genetic epilepsy with febrile seizures plus - gene mutations
identified in a minor of affected families and are usually of missense type
SCN1A, SCN1B, and GABA-A receptor geen GABRG2
truncation mutations more likely associated with more severe phenotypes
genetic epilepsy with febrile seizures plus - treatment
recognition helps guide treatment since sodium channel blockers may be deleterious in this otherwise pharmacoresponsive epilepsy
no phenytoin, carbamazepine, oxcarbazepine, and lamotrigine
genetic epilepsy with febrile seizures plus - prognosis
remits by adolescence
panayiotopoulos syndrome
early onset childhood occipital epilepsy
panayiotopoulos syndrome - onset
usually between 3 and 6 years of age, although a wide range from 1 to as late as 14yrs has been described
panayiotopoulos syndrome - features
autonomic component - bowel or bladder incontinence, pallor, pupillary changes, and syncope
can be prolonged (at least 5mins and sometimes even hrs) and feature nausea, vomiting, and eye deviation with preserved consciousness
panayiotopoulos syndrome - classic scenario
seizure with recurrent vomiting with onset during sleep
panayiotopoulos syndrome - seizures
may secondarily generalize into convulsions
ddx of focal seizure
panayiotopoulos syndrome - EEG
spikes that can be shifting and multifocal
panayiotopoulos syndrome - etiology
unknown
no positive family history
panayiotopoulos syndrome - treatment
episodes infrequent
intermittent benzodiazepine use
panayiotopoulos syndrome - prognosis
long-term remission occurs within 2 years after onset, although there is a crossover with benign epilepsy with centrotemporal spikes (BECTS)
myoclonic-atonic epilepsy (Doose syndrome)
characteristic initial myoclonic component followed by a fall
myoclonic-atonic epilepsy (Doose syndrome) - symptoms
myoclonus manifests as large-amplitude symmetric jerks of the arms, legs, neck, and shoulders that may result in a head drop and upper limb flexion or abduction
followed by loss of muscle tone and a fall
myoclonic-atonic epilepsy (Doose syndrome) - seizure types
myoclonic-atonic events
absence, tonic-clonic, and tonic
myoclonic or non convulsive status epilepticus
myoclonic-atonic epilepsy (Doose syndrome) - onset
between 18 months and 5 years of age
peak at 3 years
myoclonic-atonic epilepsy (Doose syndrome) - EEG
recurrent paroxysms of generalized spike or polyspike and wave, typically without clinical correlate and satisfactory background
parasagittal theta frequency slowing
photoparoxysmal response
myoclonic-atonic epilepsy (Doose syndrome) - myoclonic events on EEG
bursts of 2 Hz to 4 Hz epileptiform activity
myoclonic-atonic epilepsy (Doose syndrome) - genetics
family history positive for epilepsy
phenotype associated with the GEFS+ syndrome
myoclonic-atonic epilepsy (Doose syndrome) - mutations
SCN1A, SCN1B, GABRG2, SLC6A1
myoclonic-atonic epilepsy (Doose syndrome) - treatment
standard AED: valproic acid, ethosuximide, or benzodiazepines
- topiramate, lamotrigine, rufinamide, and levetiracetam may also show benefit
ketogenic diet
vagus nerve stimulator or corpus callosotomy unclear
myoclonic-atonic epilepsy (Doose syndrome) - prognosis
long-term remission in majority of patients
remainder develop intractable epilepsy with intellectual impairment
benign epilepsy with centrotemporal spikes (benign rolandic epilepsy)
25% of all childhood epilepsies
nonlesional focal epilepsy with an excellent outcome
benign epilepsy with centrotemporal spikes (benign rolandic epilepsy) - onset
4-11 years
peak 7-8
male predominance
benign epilepsy with centrotemporal spikes (benign rolandic epilepsy) - timing
shortly after sleep onset or just before awakening
1/4 have seizures during active state
benign epilepsy with centrotemporal spikes (benign rolandic epilepsy) - seizure symptomology
begin with paresthesia on one side of the tongue or mouth, followed by dysarthria or gagging-type noises, jerking of the ipsilateral face, and excessive drooling
secondary generalization may occur